Robert Sun

USPTO Granted Patents = 13 (Patent Applications = 3)

CIPO Patents = 1

EPO Patents = 9 (Patent Applications = 6)

Average Co-Inventor Count = 8.3

ph-index = 6

Forward Citations = 100(Granted Patents)

Location History:

Berkeley Heights, NJ (US) (2010)
Natick, MA (US) (2012 - 2022)

Company Filing History:

Merck Sharp + Dohme Corp.

patents

Years Active: 2010-2022

Loading Chart...

13 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11229648 - 1,4-disubstituted pyridazine analogs thereof and methods for treating SMN-deficiency-related conditions (2022-01-25),

2. 10758533 - 1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions (2020-09-01),

3. 10195196 - 1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions (2019-02-05),

4. 9603819 - Substituted aminobutyric derivatives as neprilysin inhibitors (2017-03-28),

5. 9545404 - 1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions (2017-01-17),

6. 9006249 - Substituted aminobutyric derivatives as neprilysin inhibitors (2015-04-14),

7. 8877815 - Substituted carbamoylcycloalkyl acetic acid derivatives as NEP (2014-11-04),

8. 8729263 - 1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions (2014-05-20),

9. 8575160 - Imidazole derivatives as aldosterone synthase inhibitors (2013-11-05),

10. 8546404 - Compounds that are ERK inhibitors (2013-10-01),

11. 8394853 - Substituted aminopropionic derivatives as neprilysin inhibitors (2013-03-12),

12. 8263629 - Substituted aminobutyric derivatives as neprilysin inhibitors (2012-09-11),

13. 7807672 - Compounds that are ERK inhibitors (2010-10-05),

Title: The Innovative Contributions of Inventor Robert Sun

Introduction: Robert Sun, a prolific inventor based in Natick, Massachusetts, has made significant strides in the field of medical innovations. With a commendable portfolio of 13 patents, he has been instrumental in the development of novel pharmaceutical compounds aimed at treating key medical conditions.

Latest Patents: Robert Sun's latest patents focus on 1,4-disubstituted pyridazine analogs and their therapeutic applications for treating SMN-deficiency-related conditions. His inventions provide compounds of a specific formula, alongside methods for manufacturing these compounds and outlining their therapeutic uses. Furthermore, he offers a combination of pharmacologically active agents and a comprehensive pharmaceutical composition to enhance treatment efficacy.

Career Highlights: Throughout his career, Robert Sun has worked for prominent pharmaceutical companies such as Novartis AG and Schering Corporation. His experience in these organizations has enriched his expertise and contributed to his innovative output.

Collaborations: In his journey as an inventor, Robert Sun has collaborated with talented professionals, including Atwood Kim Cheung and Donovan Noel Chin. These collaborations have fostered an environment of creativity and innovation, leading to impactful discoveries in the pharmaceutical realm.

Conclusion: Robert Sun's contributions to the field of medicine through his patents and collaborations highlight his role as a notable inventor. His work continues to pave the way for advancements in treating medical conditions, showcasing the power of innovation in improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.